Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02529618 · ClinicalTrials.gov registry record

Field Implementation of iDETECT

A clinical trial, sponsored by Emory University.

Completed
Registry status
124
Enrollment target

NCT02529618 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 124 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02529618 has completed, sponsored by Emory University.

COMPLETED
Registry status
124 participants
Enrollment target

Study Summary

The purpose of this study is to assess a new screening tool for sideline evaluation of concussion injuries in athletes. iDETECT is a new technology that combines several elements of recommended concussion screening tools into a single, portable device.

Interventions

  • DEVICE integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT)
  • DEVICE Riddell High Impact Technology (HIT) System
  • DEVICE i1 Biometrics Vector Mouth Guard

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2015-08
Est. Completion 2016-02

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02529618

The ClinicalTrials.gov registry entry for NCT02529618 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT) is the first listed.

NCT02529618 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02529618 about?

NCT02529618 is a clinical study titled "Field Implementation of iDETECT". The purpose of this study is to assess a new screening tool for sideline evaluation of concussion injuries in athletes. iDETECT is a new technology that combines several elements of recommended concussion screening tools into a single, portable device.

What is the current status of trial NCT02529618?

This trial is currently completed. The enrollment target is 124 participants. The study started on 2015-08. Estimated completion is 2016-02.

What interventions are being tested in trial NCT02529618?

The interventions under investigation include: integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT) (DEVICE), Riddell High Impact Technology (HIT) System (DEVICE), i1 Biometrics Vector Mouth Guard (DEVICE).

Who is sponsoring clinical trial NCT02529618?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.